About Us

    In 2000 the group of pharmaceutical companies Maxpharma (private limited liability companies Maxpharma Baltija, UAB, Aringa, UAB and Inteli Generics Nord, UAB) has entered into the market of generic products in the Baltic and CIS states. At present our portfolio includes more than 60 pharmaceutical formulas available to consumers in Lithuania, Latvia, Estonia, Belarus, Ukraine and Kazakhstan. We hold on the continual analysis of demand in these and other markets with the purpose of the assortment updating. Using own resources only, the company gets over all main stages of promotion of preparations: state authorization, marketing, logistics.

    We produce our preparations at 13 modern pharmaceutical factories located in Austria, India, Spain, Italy, Cyprus and Turkey. As a rule, we are registered owners of our preparations, thus assuming responsibility for their quality. Annually we conduct inspections at these enterprises in order to make sure that manufacturers are committed to the principles of the Good Medical Practice (GMP).

    Maxpharma Group of pharmaceutical companies is always ready to supply its partners with medical products produced following GMP principles, at reasonable prices and in any quantities (from ten units up to tens thousand) within the term up to 10 days. The central warehouse that meets requirements of the Good Pharmaceutical Distribution is located in Vilnius (Lithuania), as well as the central office. The goods for the Ukrainian market are stored in the warehouse in Kiev.  

    We have at our disposal the promotional divisions with staff numbering approx. 40 employees (doctors, pharmacists and marketing experts) to ensure the steady demand for our preparations.   

    Maxpharma Group of pharmaceutical companies has the solid experience of participating in tenders.

    Except for medical products, we focus our attention on the health care products and dermatological cosmetics.